Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
Nelonemdaz by GNT Pharma for Acute Ischemic Stroke: Likelihood of Approval
Nelonemdaz is under clinical development by GNT Pharma and currently in Phase I for Acute Ischemic Stroke. According to GlobalData,...
Data Insights
AAD-2004 by GNT Pharma for Amyotrophic Lateral Sclerosis: Likelihood of Approval
AAD-2004 is under clinical development by GNT Pharma and currently in Phase I for Amyotrophic Lateral Sclerosis. According to GlobalData,...